Immatics Us, Inc.
Clinical trials sponsored by Immatics Us, Inc., explained in plain language.
-
Engineered immune cells take on Hard-to-Treat cancers
Disease control Recruiting nowThis study tests a new treatment for people with solid tumors that have come back or not responded to standard care. The treatment uses the patient's own immune cells, which are modified in a lab to better recognize and attack cancer cells. Some participants will also receive an …
Phase: PHASE1, PHASE2 • Sponsor: Immatics US, Inc. • Aim: Disease control
Last updated May 01, 2026 16:01 UTC
-
New cell therapy shows promise in battle against advanced skin cancer
Disease control Recruiting nowThis phase 3 trial tests a new cell therapy called IMA203 against standard treatments for people with advanced melanoma (a serious skin cancer) that has spread or can't be removed. About 360 adults who have already tried a PD-1 inhibitor will be randomly assigned to receive IMA20…
Phase: PHASE3 • Sponsor: Immatics US, Inc. • Aim: Disease control
Last updated Apr 29, 2026 15:02 UTC